5-ht6 Receptors

被引:278
作者
Woolley, Marie L. [1 ,2 ]
Marsden, Charles A. [1 ]
Fone, Kevin C. F. [1 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Inst Neurosci, Nottingham NG7 2UH, England
[2] F Hoffmann LaRoche AG, PRBD N, CH-4070 Basel, Switzerland
关键词
D O I
10.2174/1568007043482561
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The 5-hydroxytryptamine6 (5-ht(6)) was one of the most recent additions to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent. The high affinity of a wide range of psychiatric drugs for the 5-ht(6) receptor, together with its almost exclusive expression in the CNS, being abundant in limbic and cortical regions, has stimulated significant research interest. The 5-ht(6) receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures. The current article will review all aspects of the discovery, genetics, distribution, pharmacology and function of the 5-ht(6) receptor. Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht(6) receptor to be approved and its true status recognised.
引用
收藏
页码:59 / 79
页数:21
相关论文
共 139 条
[1]   5-hydroxytryptamine 6 receptor (5-HT6) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country [J].
Alvarez-Alvareza, M ;
Galdos, L ;
Fernández-Martínez, M ;
Gómez-Busto, F ;
García-Centeno, V ;
Arias-Arias, C ;
Sánchez-Salazar, C ;
Rodríguez-Martínez, AB ;
Zarranz, JJ ;
de Pancorbo, MM .
NEUROSCIENCE LETTERS, 2003, 339 (01) :85-87
[2]  
Annesi G, 2001, AM J HUM GENET, V69, P497
[3]  
[Anonymous], 4 IUPHAR SAT M SER
[4]   Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT1A or 5-HT1B receptor knockout mice [J].
Ase, AR ;
Reader, TA ;
Hen, R ;
Riad, M ;
Descarries, L .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2415-2426
[5]  
Baader M., 2000, EUR J NEUROSCI, V12, p267P
[6]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[7]  
BENTLEY JC, 1997, J PSYCHOPHARMACOL, V11, pA64
[8]  
BENTLEY JC, 1999, BRIT J PHARMACOL, V126, pP66
[9]   A SYNAPTIC MODEL OF MEMORY - LONG-TERM POTENTIATION IN THE HIPPOCAMPUS [J].
BLISS, TVP ;
COLLINGRIDGE, GL .
NATURE, 1993, 361 (6407) :31-39
[10]   Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine(6) receptor [J].
Boess, FG ;
Monsma, FJ ;
Meyer, V ;
Zwingelstein, C ;
Sleight, AJ .
MOLECULAR PHARMACOLOGY, 1997, 52 (03) :515-523